Sally Barbour, Pharm.D., BCOP, CPP, FHOPA

Sally Yowell Barbour
Director of Oncology Pharmacy Programs; PGY2 Oncology Residency Director; Clinical Pharmacist Practitioner

Contact Information:

Education: PharmD - University of Texas
PGY1 - Pharmacy Practice, University of Illinois at Chicago
PGY2 - Oncology, The University of Texas Health Science Center

Preceptor for: Ambulatory Oncology Clinic - Thoracic Oncology, Oncology Pharmacy Management

Sally Barbour, Pharm.D., BCOP, CPP is a the Director of Oncology Pharmacy Programs and a Clinical Oncology Pharmacist at the Duke Cancer Institute at Duke University Medical Center. In addition to her leadership responsibilities, she maintains a clinical practice in the adult outpatient oncology clinics. She earned her BA from Duke University and her PharmD degree from the University of Texas at Austin. She completed a residency in Pharmacy Practice at the University of Illinois at Chicago and in Oncology Pharmacy Practice at the Audie L. Murphy VA and University of Texas Health Science Center in San Antonio. She obtained her board certification in oncology pharmacy in 2001 and her clinical pharmacist practitioner certification in 2005. Dr. Barbour serves as a member of the NCCN Antiemesis Panel and the Pharmacy Committee for CALGB. She is a member of ASCO, ACCP, ASHP and HOPA, where she has served on various committees as both a member and committee leader. She co-founded the North Carolina Oncology Pharmacists Association in 2001 and co-plans their annual meeting. Dr. Barbour has developed numerous supportive care guidelines at Duke and lectured on topics related to CINV, myelosuppression, general supportive care, lung cancer, oral chemotherapy and the role of pharmacy in oncology practice.